Vidac Pharma Holding Plc (ETR:T9G)
Germany · Delayed Price · Currency is EUR 0.4630
+0.0650 (16.33%)
At close: Sep 15, 2026
Vidac Pharma Holding Market Cap
Vidac Pharma Holding has a market cap or net worth of €20.55 million as of September 15, 2026.
Market Cap
20.55M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.46
ChartMarket Cap Chart
Since December 15, 2025, Vidac Pharma Holding's market cap has decreased from 26.85M to 20.55M, a decrease of -23.46%. That is a compound annual growth rate of -29.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 23.90M | -13.62% |
| Dec 30, 2025 | 27.67M | 3.08% |
| Dec 15, 2025 | 26.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 84.00M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 29.39M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 274.58K |
| MagForce AG | 91.72K |